CaMKII(δ) regulates osteoclastogenesis through ERK, JNK, and p38 MAPKs and CREB signalling pathway

Mol Cell Endocrinol. 2020 May 15:508:110791. doi: 10.1016/j.mce.2020.110791. Epub 2020 Mar 12.

Abstract

Calcium/calmodulin-dependent protein kinases (CaMKs) are a group of important molecules mediating calcium signal transmission and have been proved to participate in osteoclastogenesis regulation. CaMKII, a subtype of CaMKs is expressed during osteoclast differentiation, but its role in osteoclastogenesis regulation remains controversial. In the present study, we identified that both mRNA and protein levels of CaMKII (δ) were upregulated in a time-dependent manner during osteoclast differentiation. CaMKII (δ) gene silencing significantly inhibited osteoclast formation, bone resorption, and expression of osteoclast-related genes, including nuclear factor of activated T cells c1 (NFATc1), tartrate-resistant acid phosphatase (TRAP), and c-Src. Furthermore, CaMKII (δ) gene silencing downregulated phosphorylation of mitogen-activated protein kinases (MAPKs), including JNK, ERK, and p38, which were transiently activated by RANKL. Specific inhibitors of ERK, JNK, and p38 also markedly inhibited expression of osteoclast-related genes, osteoclast formation, and bone resorption like CaMKII (δ) gene silencing. Additionally, CaMKII (δ) gene silencing also suppressed RANKL-triggered CREB phosphorylation. Collectively, these data demonstrate the important role of CaMKII (δ) in osteoclastogenesis regulation through JNK, ERK, and p38 MAPKs and CREB pathway.

Keywords: Calcium/calmodulin-dependent protein kinases; Extracellular signal-regulated kinases; Osteoclast; c-Jun amino-terminal kinases; cAMP response element binding protein; p38.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Resorption / genetics
  • Bone Resorption / pathology
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism*
  • Cell Differentiation / drug effects
  • Cyclic AMP Response Element-Binding Protein / metabolism*
  • Down-Regulation / drug effects
  • Down-Regulation / genetics
  • Extracellular Signal-Regulated MAP Kinases / metabolism*
  • Gene Silencing / drug effects
  • JNK Mitogen-Activated Protein Kinases / metabolism*
  • Mice
  • Osteoclasts / cytology
  • Osteoclasts / drug effects
  • Osteoclasts / metabolism*
  • Osteogenesis* / drug effects
  • Phosphorylation / drug effects
  • Protein Kinase Inhibitors / pharmacology
  • RANK Ligand / pharmacology
  • RAW 264.7 Cells
  • Signal Transduction* / drug effects
  • Tartrate-Resistant Acid Phosphatase / metabolism
  • Time Factors
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Cyclic AMP Response Element-Binding Protein
  • Protein Kinase Inhibitors
  • RANK Ligand
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Extracellular Signal-Regulated MAP Kinases
  • JNK Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Tartrate-Resistant Acid Phosphatase